- Meeting abstract
- Open Access
Long-term retention of non-funcionalized carbon nanotubes in nod mice and its influence on the evolution of autoimmune diabetes
- Daniela da Silva Camilo1,
- Adriel dos Santos Moraes1,
- Fernando Pradella1,
- Guliherme Antonio Dutra Moraes1,
- Rosemeire Florença de Oliveira de Paula1,
- Elaine Conceição de Oliveira1,
- Gustavo Ferreira Simões1,
- Alexandre Leite Rodrigues de Oliveira1,
- Helder José Ceragioli1,
- Vitor Baranauskas1,
- Aureo Tatsumi Yamada1,
- Alessandro Santos Farias1,
- Leonilda Maria Barbosa dos Santos1 and
- Walkyria Mara Gonçalves Volpini1Email author
© da Silva Camilo et al. 2015
- Published: 11 November 2015
- Carbon Nanotubes
- Pancreatic Duct
- Autoimmune Diabetes
- Clinical Diabetes
- Diabetes Onset
The perspectives of using carbon nanotubes (CNTs) in medicine evoked many researches aiming to evaluate their risks on the human health as well as on the environment.
This study focuses the long-term effects of the systemic administration of non-functionalized multi-walled carbon nanotubes (MWCTNs) on the evolution of spontaneous autoimmune diabetes in Non-Obese Diabetic (NOD) mice.
The protocol consisted in treating 6 weeks old NOD/Uni mice with a single intra-peritoneal dose of MWCTN (100 μg/animal) or the vehicle Pluronic (control group). Mice were followed during 24 weeks.
Histological data confirmed that the non-functionalized MWCTN had been absorbed and kept retained into the phagocytes of the peri-pancreatic lymph nodes, spleen and liver, causing a granulomatous inflammatory response. Even though no differences were found in the frequency of the development of clinical diabetes or in the morphological characteristics of the pancreatic insulitis, female NOD mice treated with MWCTN presented a significant higher fluctuation of the average glycaemia compared to the control group during the entire study (p<0.0001; Wilcoxon), with a tendency to an abbreviation of clinical diabetes onset. Analyses of the pro-inflammatory and the anti-inflammatory responses in the peri-pancreatic lymph nodes revealed the induction of a Th1 response in the treated animals, between 8 and 14 after MWCTN exposition, with an increase of the expression of IFNγ and a reduced expression of TGFβ. This profile remained until the end of the study, 24 weeks after MWCTN injection.
These data show that MWCTN may be retained for at least 6 months in lymph nodes and pancreatic ducts of NOD mice. Therefore, despite the evident need of modifying nanotubes, it is important to consider the high risks of exposing these molecules to humans, since chronic inflammation may be related to the development and/or the aggravation of autoimmune diseases.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.